Pfanstiel Steven 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Pfanstiel Steven
CFO AND COO
Transactions
- Award
Common Stock
2024-06-18+12,733→ 84,430 total - Award
Stock Option (Right to Buy)
2024-06-18+57,300→ 57,300 totalExercise: $1.40Exp: 2034-06-18→ Common Stock (57,300 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.